Literature DB >> 27251192

Optical coherence tomography manifestations of primary vitreoretinal lymphoma.

Teiko Saito1, Nobuyuki Ohguro2,3, Chiharu Iwahashi4, Noriyasu Hashida4.   

Abstract

BACKGROUND: Primary vitreoretinal lymphoma (PVRL), a subset of primary central nervous system lymphoma (PCNSL), is a high-grade malignant tumor that shows various chorioretinal findings. Optical coherence tomography (OCT) is useful for detecting these lesions, and various abnormalities on OCT images have been reported. The purpose of this report was to investigate retrospectively the OCT manifestations of various disease stages and compare the manifestations of pretreatment, recurrent, and chronic cases.
METHODS: We reviewed the medical charts and OCT images of 38 consecutive cases with PVRL. When abnormalities were detected on OCT images, the patients were classified based on the treatment of the primary disease: pretreatment if not treated, recurrent if treated previously, and chronic when chronic changes.
RESULTS: Twenty-six eyes (20 cases) had abnormalities in the post-pole OCT images, i.e., 16 eyes (12 cases) were in the pretreatment group, seven eyes (five cases) were in the recurrent group, and five eyes (five cases) were in the chronic group. Two eyes (two cases) had abnormalities on OCT in the pretreatment and recurrent or chronic stages. The pretreatment and recurrent groups had subretinal or retinal pigment epithelium (RPE) level abnormalities more often than intraretinal changes. Twelve of 16 pretreated eyes and all seven eyes with recurrent disease had subretinal or RPE level abnormalities. One pretreatment case and three recurrent cases had atypical OCT manifestations of intraretinal (round lesions) or epiretinal changes (villous-shaped lesions).
CONCLUSIONS: Although pretreatment cases and recurrent cases showed similar OCT abnormalities and the specific changes in the various disease stages were unclarified, collecting OCT data from various disease stages will facilitate detection of typical OCT changes of PVRL and lead to early diagnosis and treatment.

Entities:  

Keywords:  Intraocular lymphoma; Optical coherence tomography; Primary vitreoretinal lymphoma

Mesh:

Year:  2016        PMID: 27251192     DOI: 10.1007/s00417-016-3395-x

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  14 in total

1.  Clinical features and diagnostic significance of the intraocular fluid of 217 patients with intraocular lymphoma.

Authors:  Keisuke Kimura; Yoshihiko Usui; Hiroshi Goto
Journal:  Jpn J Ophthalmol       Date:  2012-06-05       Impact factor: 2.447

2.  Combination intravitreal rituximab and methotrexate for massive subretinal lymphoma.

Authors:  S Yeh; D J Wilson
Journal:  Eye (Lond)       Date:  2010-08-13       Impact factor: 3.775

3.  High-definition optical coherence tomography features of primary vitreoretinal lymphoma.

Authors:  Farzin Forooghian; Andrew B Merkur; Valerie A White; Defen Shen; Chi-Chao Chan
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2011-09-29

4.  Subretinal lymphomatous infiltration in primary intraocular lymphoma revealed by optical coherence tomography.

Authors:  Feng Liang; Pierre Olivier Barale; Khé Hoang Xuan; Michel Paques; José-Alain Sahel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-04-21       Impact factor: 3.117

5.  Repeated IL-10 measurement in aqueous humor and OCT imaging are valuable tools to monitor intraocular lymphoma treated with intravitreal injections of methotrexate.

Authors:  Maher Saleh; Katerina Nikolitch; Tristan Bourcier; Claude Speeg; David Gaucher
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-07-15       Impact factor: 3.117

Review 6.  Variations in the presentation of primary intraocular lymphoma: case reports and a review.

Authors:  M K Gill; L M Jampol
Journal:  Surv Ophthalmol       Date:  2001 May-Jun       Impact factor: 6.048

Review 7.  Diagnostic testing and treatment choices in primary vitreoretinal lymphoma.

Authors:  Rithwick Rajagopal; J William Harbour
Journal:  Retina       Date:  2011-03       Impact factor: 4.256

8.  Treatment of primary intraocular lymphoma with intravitreal methotrexate.

Authors:  Reika Sou; Nobuyuki Ohguro; Tetsuo Maeda; Yoshitsugu Saishin; Yasuo Tano
Journal:  Jpn J Ophthalmol       Date:  2008-07-27       Impact factor: 2.447

9.  Fundus autofluorescence patterns in eyes with primary intraocular lymphoma.

Authors:  Tomoka Ishida; Kyoko Ohno-Matsui; Yuh Kaneko; Hideaki Tobita; Noriaki Shimada; Hiroshi Takase; Manabu Mochizuki
Journal:  Retina       Date:  2010-01       Impact factor: 4.256

10.  Retinal fluorescein, indocyanine green angiography, and optic coherence tomography in non-Hodgkin primary intraocular lymphoma.

Authors:  Christine Fardeau; Cheryl P L Lee; Hélène Merle-Béral; Nathalie Cassoux; Bahram Bodaghi; Frédéric Davi; Phuc Lehoang
Journal:  Am J Ophthalmol       Date:  2009-02-25       Impact factor: 5.258

View more
  11 in total

1.  Diffuse Uveal Melanocytic Proliferation With Primary Vitreoretinal Lymphoma.

Authors:  Ilya Leskov; Alice T Lyon; Lee M Jampol
Journal:  JAMA Ophthalmol       Date:  2019-07-01       Impact factor: 7.389

2.  Vertical Hyperreflective Lesions on Optical Coherence Tomography in Vitreoretinal Lymphoma.

Authors:  Gábor Gy Deák; Debra A Goldstein; Mei Zhou; Amani A Fawzi; Lee M Jampol
Journal:  JAMA Ophthalmol       Date:  2019-02-01       Impact factor: 7.389

Review 3.  Macular edema is a rare finding in untreated vitreoretinal lymphoma: small case series and review of the literature.

Authors:  Elisa Carreras; Diva R Salomão; Jeroni Nadal; Sejal R Amin; Harish Raja; Thomas J Grube; Ryan L Geraets; Patrick B Johnston; Brian P O'Neill; Jose S Pulido
Journal:  Int J Retina Vitreous       Date:  2017-04-24

4.  The use of anterior segment optical coherence tomography (ASOCT) in demonstrating recurrence of vitreoretinal lymphoma (VRL) in the anterior vitreous.

Authors:  Vlad Diaconita; Heba Rihani; Virginia Mares; Marcio B Nehemy; Sophie J Bakri; Jose S Pulido
Journal:  Int J Retina Vitreous       Date:  2019-08-20

5.  Changes in choroidal vascular structure from vitreoretinal lymphoma and the intraocular cytokine level associated with clinical resolution after intravitreal methotrexate treatment.

Authors:  Rae-Young Kim; Jae Hyun Park; Mirinae Kim; Young-Geun Park; Seok-Goo Cho; Young-Hoon Park
Journal:  PLoS One       Date:  2021-11-23       Impact factor: 3.240

6.  Clinical Features, Diagnosis, Management and Prognosis of Primary Intraocular Lymphoma.

Authors:  Xin-Yu Zhao; Tian-Tian Cheng; Li-Hui Meng; Wen-Fei Zhang; You-Xin Chen
Journal:  Front Oncol       Date:  2022-02-03       Impact factor: 6.244

7.  Diagnostic Accuracy of Cell Block Preparations and Clinical Features Affecting It in Vitreoretinal Lymphoma.

Authors:  Satoru Kase; Kenichi Namba; Daiju Iwata; Kazuomi Mizuuchi; Kayo Suzuki; Takako Ito; Keitaro Hase; Nobuyoshi Kitaichi; Susumu Ishida
Journal:  J Clin Med       Date:  2022-03-03       Impact factor: 4.241

8.  Optical Coherence Tomography Benefits the Diagnosis and Follow-Up of Primary Central Nervous System Lymphoma with Intraocular Involvement.

Authors:  Xianjin Zhou; Sha Tian; Xian Zhou; Huimin Shi; Yi Li; Jianjiang Xiao; Kun Chen; Bobin Chen; Gezhi Xu; Qingping Wang
Journal:  Cancer Manag Res       Date:  2022-03-05       Impact factor: 3.989

9.  Retinal changes of primary vitreoretinal lymphoma after intravitreal methotrexate.

Authors:  Tingting Jiang; Junxiang Gu; Shixue Liu; Qing Chang
Journal:  BMC Ophthalmol       Date:  2022-09-20       Impact factor: 2.086

10.  Longitudinal observation of OCT imaging is a valuable tool to monitor primary vitreoretinal lymphoma treated with intravitreal injections of methotrexate.

Authors:  Huiying Zhao; Xiaona Wang; Yu Mao; Xiaoyan Peng
Journal:  BMC Ophthalmol       Date:  2020-01-06       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.